Current Edition

news

Innovent receives IND approval to initiate Clinical Trials in China

Innovent’s IBI101, is the first OX40-targeted molecule to receive IND approval in China Innovent Biologics, a world-class China-based biopharmaceutical company that develops and intends to …

Continue Reading →
news

Now your smartphone camera can perform clinical urinalysis at home

U.S. FDA Grants Landmark Class II Approval for Clinical Grade Smartphone Testing – Healthy.io’s Dip.io Urinalysis Israel based Healthy.io, the first company in the world …

Continue Reading →
news

Cannabics Pharma clinches clinical trial on Cannabics SR 5mg for CACS

The company is awaiting for the results and expect them to further clarify an important part of their mission in integrating cannabinoid-based therapies into the …

Continue Reading →
news

Vertex, CRISPR gene-editing therapy hit with clinical hold

U.S. regulators have placed a clinical hold on CRISPR Therapeutics’ lead candidate, spurring a double-digit drop in the Swiss biotech’s stock value by Thursday morning. …

Continue Reading →